New York, NY (PRWEB) June 28, 2013
Bernstein Liebhard LLP has launched a new Byetta lawsuit website devoted to supplying data to patients who could have created pancreatitis, pancreatic cancer or thyroid cancer as a result of the diabetes drug.

The Firm is actively investigating the hazardous pancreatic dangers related with Byetta, a sort II diabetes drug involved in a class of drugs known as incretin mimetics. In addition to its new internet site, which contains information associated to side effects, as effectively as updates on the increasing nationwide litigation involving Byetta and other incretin mimetics which includes Januvia, Bernstein Liebhard LLP is providing totally free and confidential case evaluations to any person who may possibly have been diagnosed with any of the following diseases soon after taking the diabetes medication: